John Noseworthy Elected to Mitre Board of Trustees; Jason Providakes Quoted

John Noseworthy, president and CEO emeritus at Rochester, Minn.-based nonprofit medical center Mayo Clinic, has been appointed to serve on Mitre’s board of trustees for a term of up to three years.

He will support Mitre in efforts to grow its involvement in health care and pandemic response initiatives such as the COVID-19 Healthcare Coalition, the nonprofit corporation said Tuesday.

From 2009 to 2019, Noseworthy led Mayo Clinic’s execution of care delivery strategies as its CEO. He previously held consultant and medical director roles at the hospital’s neurology and development departments.

He is also recognized as a medical expert in multiple sclerosis and has facilitated controlled clinical trials over the past two decades.

"His strategic insight and vast healthcare leadership experience support our continued growth efforts in the healthcare sector, especially our critical work surrounding the COVID-19 crisis as well, as planning for future pandemics with the creation of a national pandemic platform," said Jason Providakes, president and CEO of Mitre and two-time Wash100 Award recipient.

The company co-chairs the COVID-19 Healthcare Coalition with Mayo Clinic and operates a federally funded research and development center for the Centers for Medicare and Medicaid Services.

You may also be interested in...

Naval Strike Missile

State Dept Clears $300M Sale of Raytheon Technologies-Made Naval Missiles to Romania

The State Department approved Romania's request to buy anti-ship missile systems manufactured by Raytheon Technologies (NYSE: RTX) through a potential $300M foreign military sale transaction with the U.S. government. The company's missiles and defense business would deliver two units of the Naval Strike Missile Coastal Defense System and complementary equipment to Romania's government under the potential deal, the Defense Security Cooperation Agency said Friday.

August Jackson Senior Director Deltek

ArchIntel’s AI in Competitive Intelligence Virtual Event to Discuss Maintaining Competitive Advantage

Artificial intelligence (AI), machine learning (ML) and big data have transformed how businesses conduct competitive intelligence (CI) and how our stakeholders use the developed analyses. Additionally, the federal government has integrated emerging technologies to remain competitive across the defense landscape. To register for ArchIntel’s AI in Competitive Intelligence Virtual Event, as well as view upcoming opportunities, visit ArchIntel’s Event Page.